Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00031783
DRKS00031783
Recruiting
Not Applicable

Retrospective evaluation of abdominal MRI imaging: prognostic value and therapy monitoring in patients with pancreatic neuroendocrine tumors receiving capecitabine and temozolomide (Cap/Tem) therapy - PNET_MRT_CAP/TEM

MU München0 sites100 target enrollmentSeptember 18, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsD44D37.7D47Neoplasm of uncertain or unknown behaviour of endocrine glandsOther digestive organsOther neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
D44
Sponsor
MU München
Enrollment
100
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 18, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
MU München

Eligibility Criteria

Inclusion Criteria

  • •\> 18 years
  • •\- NET pancreas
  • •\- Abdominal MRI imaging before therapy and after Cap/Tem therapy, if applicable.
  • •\- Cap/Tem therapy

Exclusion Criteria

  • •\- \< 18 years
  • •\- Incomplete examinations due to premature termination
  • •\- Limited image quality due to artifacts

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
evaluation of cine MRI and abdominal symptomsPatients with abdominal symptoms (functional dyspepsia, chronic constipation) and healthy volunteers
JPRN-UMIN000041988Juntendo University school of Medicine70
Recruiting
Not Applicable
Study for optimaization of abdominal MRI and evaluation of abdominal functional MRIadults with abdominal diseases who will undergo or underwent abdominal MRI
JPRN-UMIN000003143Department of Radiology Kobe University Graduate School of Medicine500
Completed
Not Applicable
Retrospective Investigation of CT and MRI Imaging Features of Tubulocystic Renal Cell Carcinoma.Tubulocystic Renal Cell Carcinoma(TC-RCC), Collecting Duct Carcinoma(CDC), Papillary Renal Cell Carcinoma(P-RCC), Multilocular Cystic Renal Cell Carcinoma(MC-RCC), Cystic Nephroma(CN), Mixed Epithelial and Stromal Tumor of Kidney(MEST)
JPRN-UMIN000023309Institute and Graduate School of Biomedical Sciences. Hiroshima University200
Active, not recruiting
Phase 1
Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron OverloadMedDRA version: 19.0Level: LLTClassification code 10028534Term: Myelodysplastic syndrome NOSSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2016-000246-62-Outside-EU/EEAovartis53
Not yet recruiting
Not Applicable
A study of Magnetic Resonance Imaging(MRI) evaluation in knee joint pathologies.
CTRI/2018/05/013938Department of Radiodiagnosis Government Medical College and Sir T HospitalBhavnagar